Popular allergy drugs eyed for over-the-counter sales

Article Abstract:

The proposal to classify anti-allergy drugs Claritin, Allegra and Zyrtec, as over-the-counter medications has the pharmaceutical industry clashing with health insurers. The latter group want to see the drugs sold over the counter, claiming such a move will reduce their prices. On the other hand, pharmaceutical companies say health insurers are just trying to pass up costs to patients. They argue that insurers would stop covering these drugs, once they are sold without prescriptions.

Antihistamine Preparations, Antihistamines

---

Eli Lilly loses fight for Prozac

Article Abstract:

Share prices of Eli Lilly fell sharply after an appeals court ruled that Barr Laboratories can sell a lower-priced version of Prozac. The company lost almost $37 billion in market value as its shares fell by 30% from $76 to $32.56. The ruling also means that Eli Lilly will not be inclined to introduce a better version of its original antidepressant drug and that consumers may be able to buy Barr's generic version at prices 25% to 35% lower than brand-name Prozac.

Patents & copyrights, Antidepressant Preparations, Eli Lilly and Co., Antidepressants

---

Drugmakers, stores move on FDA ban

Article Abstract:

Pharmaceutical companies are planning to halt production and shipping of products that contain the phenylpropanolamine (PPA) in the face of an FDA ruling on the ingredient. PPA, which is a key ingredient in cold remedies and diet drugs, is found to cause hemorrhagic stroke, particularly in young women. The move to halt production is expected to have little effect in most of the large drug companies since the remedies are only a small percentage of total sales.

Proprietary Cold Preps

Similar abstracts:

• Abstracts: Child's play doesn't pay for small TV producers. Consumers still wait for video-on-demand. Small video stores fight back
• Abstracts: Higher rates blamed for slower pace of car sales. Car sales stall, but set record in 2000. Truck sales to rise, outpace autos
• Abstracts: PeoplePC finds niche in corporate sales. Cisco sales rise 66%, as profits exceed expectations. Days of plenty are over at free Internet services
• Abstracts: Businesses need to speed if they want to succeed. Welch: Nurture best workers, lose bottom 10%. Corning chief says keep open mind, challege strategy
• Abstracts: Coke plan to buy Quaker for $16B in stock collapses. Pepsi One ads hint at sex and the soft drink. For Coke, mixed reviews bubble on top

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.